Home » Topics » BioWorld Science

BioWorld Science
RSS

BioAegis cleared to begin phase II study of rhu-pGSN in severe COVID-19 pneumonia

July 16, 2020

Octapharma reports on use of Octagam IVIG in critically ill patients with COVID-19

July 16, 2020

RBM-007 enters phase I study for treatment of achondroplasia

July 16, 2020

FDA clears IND for clinical evaluation of long-acting human IL-7 NT-17 for mild COVID-19

July 16, 2020

CS-3003, an HDAC6 inhibitor, shows promise for treating multiple myeloma

July 16, 2020

Zydus begins human dosing with ZyCoV-D vaccine

July 16, 2020

Byondis initiates phase II study of SYD-985 in advanced endometrial cancer

July 16, 2020

Can-Fite amends phase II COVID-19 study protocol based on FDA guidance

July 16, 2020

Novocure and MSD to study Tumor Treating Fields with Keytruda in NSCLC

July 16, 2020

First child dosed in phase II study of infigratinib in achondroplasia

July 16, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...